Overview on Controlled Drug Delivery System

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

Abhishek Pravin Patil; Adesh Bhanudas Ghadage; Ms. Radhika. S. Subhedar; Dr. Nilesh. B. Chougule

Overview on Controlled Drug Delivery System

Authors: Abhishek Pravin Patil, Adesh Bhanudas Ghadage, Ms. Radhika. S. Subhedar, Dr. Nilesh. B. Chougule

Unique Paper ID: 162223
Volume: 10
Issue: 8
PageNo: 543-551

Keywords: controlled release dissolution diffusion polymers oral parenteral matrix encapsulation reservoir ionisation dissociation.

Abstract:
Controlled Drug Delivery Systems (CDDS) have revolutionized pharmaceuticals by enabling precise control over drug release within the body. Beginning in the mid-20th century with basic sustained-release formulations, CDDS has progressed significantly, encompassing various types like reservoir, matrix, and targeted systems. These systems employ diverse approaches such as diffusion-controlled, stimuli-responsive, and implantable devices to regulate drug delivery. Polymers play a pivotal role in CDDS, influencing release kinetics. Both natural (e.g., chitosan) and synthetic polymers (e.g., PLGA) are utilized, determining release rates based on their biodegradability and compatibility with drugs. Design and performance of CDDS depend on multiple factors including drug characteristics, choice of polymers, device design, and environmental conditions. The advantages of CDDS include improved therapeutic outcomes, reduced side effects, and enhanced patient compliance. However, challenges like complex manufacturing processes and potential issues like dose variability exist. The future of CDDS holds promise in personalized medicine, nanotechnology-driven smart drug delivery, and bioengineered systems, paving the way for highly tailored therapies and further advancements in healthcare.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 10
Issue: 8
PageNo: 543-551

Overview on Controlled Drug Delivery System

Available:https://ijirt.org/article?manuscript=162223

30 Jun, 2024

Preparation, Evaluation and Optimization of Antidiabetic in-situ gel of Pioglitazone

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now